Certain LDL-C-lowering genetic variants associated with higher risk of type 2 diabetes
Date:
October 4, 2016
Source:
JAMA - Journal of the American Medical Association
Summary:
The associations with type 2 diabetes and coronary artery disease of low-density lipoprotein cholesterol (LDL-C)-lowering genetic variants have been the focus of recent study.
Share:
AddThis Sharing Buttons
Share to FacebookShare to TwitterShare to Google+Share to LinkedInShare to MoreShare to Email
FULL STORY
Treatment with statins, the pharmacological agents of choice for LDL-C-lowering therapy in cardiovascular prevention, is associated with weight gain and a higher incidence of new-onset type 2 diabetes, say researchers.
Credit: © JJAVA / Fotolia
In a study appearing in the October 4 issue of JAMA, Luca A. Lotta, M.D., Ph.D., of the University of Cambridge, U.K., and colleagues examined the associations with type 2 diabetes and coronary artery disease of low-density lipoprotein cholesterol (LDL-C)-lowering genetic variants. Treatment with statins, the pharmacological agents of choice for LDL-C-lowering therapy in cardiovascular prevention, is associated with weight gain and a higher incidence of new-onset type 2 diabetes.
https://www.sciencedaily.com/releases/2016/10/161004111653.htm
